These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 11327761

  • 1. Functional mutagenesis of AML1/RUNX1 and PEBP2 beta/CBF beta define distinct, non-overlapping sites for DNA recognition and heterodimerization by the Runt domain.
    Nagata T, Werner MH.
    J Mol Biol; 2001 Apr 27; 308(2):191-203. PubMed ID: 11327761
    [Abstract] [Full Text] [Related]

  • 2. The leukemia-associated AML1 (Runx1)--CBF beta complex functions as a DNA-induced molecular clamp.
    Bravo J, Li Z, Speck NA, Warren AJ.
    Nat Struct Biol; 2001 Apr 27; 8(4):371-8. PubMed ID: 11276260
    [Abstract] [Full Text] [Related]

  • 3. Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain.
    Nagata T, Gupta V, Sorce D, Kim WY, Sali A, Chait BT, Shigesada K, Ito Y, Werner MH.
    Nat Struct Biol; 1999 Jul 27; 6(7):615-9. PubMed ID: 10404214
    [Abstract] [Full Text] [Related]

  • 4. Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha.
    Ogawa E, Inuzuka M, Maruyama M, Satake M, Naito-Fujimoto M, Ito Y, Shigesada K.
    Virology; 1993 May 27; 194(1):314-31. PubMed ID: 8386878
    [Abstract] [Full Text] [Related]

  • 5. Molecular insights into PEBP2/CBF beta-SMMHC associated acute leukemia revealed from the structure of PEBP2/CBF beta.
    Goger M, Gupta V, Kim WY, Shigesada K, Ito Y, Werner MH.
    Nat Struct Biol; 1999 Jul 27; 6(7):620-3. PubMed ID: 10404215
    [Abstract] [Full Text] [Related]

  • 6. CBFbeta allosterically regulates the Runx1 Runt domain via a dynamic conformational equilibrium.
    Yan J, Liu Y, Lukasik SM, Speck NA, Bushweller JH.
    Nat Struct Mol Biol; 2004 Sep 27; 11(9):901-6. PubMed ID: 15322525
    [Abstract] [Full Text] [Related]

  • 7. Solution structure of core binding factor beta and map of the CBF alpha binding site.
    Huang X, Peng JW, Speck NA, Bushweller JH.
    Nat Struct Biol; 1999 Jul 27; 6(7):624-7. PubMed ID: 10404216
    [Abstract] [Full Text] [Related]

  • 8. Core-binding factor beta interacts with Runx2 and is required for skeletal development.
    Yoshida CA, Furuichi T, Fujita T, Fukuyama R, Kanatani N, Kobayashi S, Satake M, Takada K, Komori T.
    Nat Genet; 2002 Dec 27; 32(4):633-8. PubMed ID: 12434152
    [Abstract] [Full Text] [Related]

  • 9. Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation.
    Huang G, Shigesada K, Ito K, Wee HJ, Yokomizo T, Ito Y.
    EMBO J; 2001 Feb 15; 20(4):723-33. PubMed ID: 11179217
    [Abstract] [Full Text] [Related]

  • 10. Functional domains of the t(8;21) fusion protein, AML-1/ETO.
    Lenny N, Meyers S, Hiebert SW.
    Oncogene; 1995 Nov 02; 11(9):1761-9. PubMed ID: 7478604
    [Abstract] [Full Text] [Related]

  • 11. Cleidocranial dysplasia with severe parietal bone dysplasia: C-terminal RUNX2 mutations.
    Cunningham ML, Seto ML, Hing AV, Bull MJ, Hopkin RJ, Leppig KA.
    Birth Defects Res A Clin Mol Teratol; 2006 Feb 02; 76(2):78-85. PubMed ID: 16463420
    [Abstract] [Full Text] [Related]

  • 12. Oncogenic potential of the RUNX gene family: 'overview'.
    Ito Y.
    Oncogene; 2004 May 24; 23(24):4198-208. PubMed ID: 15156173
    [Abstract] [Full Text] [Related]

  • 13. Runt domains take the lead in hematopoiesis and osteogenesis.
    Werner MH, Shigesada K, Ito Y.
    Nat Med; 1999 Dec 24; 5(12):1356-7. PubMed ID: 10581073
    [No Abstract] [Full Text] [Related]

  • 14. Mutagenesis of the Runt domain defines two energetic hot spots for heterodimerization with the core binding factor beta subunit.
    Zhang L, Li Z, Yan J, Pradhan P, Corpora T, Cheney MD, Bravo J, Warren AJ, Bushweller JH, Speck NA.
    J Biol Chem; 2003 Aug 29; 278(35):33097-104. PubMed ID: 12807883
    [Abstract] [Full Text] [Related]

  • 15. Altered affinity of CBF beta-SMMHC for Runx1 explains its role in leukemogenesis.
    Lukasik SM, Zhang L, Corpora T, Tomanicek S, Li Y, Kundu M, Hartman K, Liu PP, Laue TM, Biltonen RL, Speck NA, Bushweller JH.
    Nat Struct Biol; 2002 Sep 29; 9(9):674-9. PubMed ID: 12172539
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc.
    Fieber W, Schneider ML, Matt T, Kräutler B, Konrat R, Bister K.
    J Mol Biol; 2001 Apr 13; 307(5):1395-410. PubMed ID: 11292350
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Site-directed mutagenesis supports a three-dimensional model of the runt domain.
    Levanon D, Eisenstein M, Groner Y.
    J Mol Biol; 1998 Apr 03; 277(3):509-12. PubMed ID: 9533875
    [Abstract] [Full Text] [Related]

  • 20. Isolation of PEBP2 alpha B cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1.
    Bae SC, Yamaguchi-Iwai Y, Ogawa E, Maruyama M, Inuzuka M, Kagoshima H, Shigesada K, Satake M, Ito Y.
    Oncogene; 1993 Mar 03; 8(3):809-14. PubMed ID: 8437866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.